OncoZenge AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 21, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	74	44	36	64	135	-
Market Cap Growth	78.13%	21.36%	-43.82%	-52.42%	-	-
Enterprise Value	70	38	20	32	80	-
Last Close Price	5.84	3.75	3.09	5.50	11.56	-
PS Ratio	26.54	43924.67	12064.64	-	-	-
PB Ratio	7.94	4.42	1.94	1.90	1.69	-
P/TBV Ratio	30.10	14.17	3.07	2.38	1.84	-
EV/Sales Ratio	25.07	38094.67	6750.97	-	-	-
EV/EBITDA Ratio	-	-	2.79	11.43	-	-
Asset Turnover	0.17	0	0	-	-	-
Quick Ratio	4.13	2.95	7.81	10.22	10.62	1.72
Current Ratio	4.28	3.09	7.94	10.29	10.63	1.72
Return on Equity (ROE)	-78.64%	-60.77%	-60.45%	-81.62%	-7.09%	-
Return on Assets (ROA)	-31.88%	-34.17%	-34.73%	-20.88%	-4.95%	-
Return on Capital Employed (ROCE)	-50.80%	-87.30%	-85.30%	-60.10%	-6.10%	-2.70%
Earnings Yield	-11.58%	-19.78%	-43.94%	-72.41%	-2.87%	-
Buyback Yield / Dilution	-1.57%	-	-	0.53%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.